Mr. Gifford leads The Foundry in all of its activities, including the identification and early development of new technologies, the formation, staffing and growth of new companies, and serving as a board member of the new ventures.
Most recently, Mr. Gifford was Vice President of Research and Development at Heartport, Inc.. From 1993-1998, he built and led a 62-person team developing a wide variety of novel devices and procedures for Minimally Invasive Cardiac Surgery that were instrumental in the company's enormously successful public offering in 1996. Heartport's market capitalization at its peak in 1996 reached over $1 billion.
In 1992, Mr. Gifford and Professor Dr. Berthold Hoefling co-founded Bavaria Medizin Technologie (BMT), GmbH, to develop innovative drug delivery catheters and to establish a German source for innovation and production of catheters for Interventional Cardiology. During the two-year period following the founding of this business, he served in the role of Managing Director of BMT until such time as he transitioned management of the company to a German national.
In 1990, Mr. Gifford and John B. Simpson, MD, Ph.D., founded Cardiovascular Therapeutic Technologies, Inc., a business devoted to the development of innovative local drug delivery catheters for thrombolytic and antiproliferative agents. Eli Lilly and Company acquired this business for its technology in 1991, and it became the original basis for Guidant's Compass organization.
From 1985-1990, Mr. Gifford worked at Devices for Vascular Intervention (DVI), where he was the driving force behind the design of the company's first generation Peripheral and Coronary atherectomy systems. In addition, during this period he served in various Clinical Research and Marketing capacities.
Before joining DVI, Hanson worked in an engineering role at Oximetrix, Inc., working in the field of intravascular blood gas monitoring equipment and supplies.
Mr. Gifford is an inventor on over fifty issued patents. He has developed catheters and accessories for numerous applications in the field of Interventional Cardiology and Radiology, Anesthesia and Cardiac Surgery. These systems have included devices for atherectomy, angioplasty, local drug delivery, heart valve replacement, and intravascular monitoring. He earned his B.S. degree in mechanical engineering from Cornell University. Mr. Gifford serves as a Director for Concentric Medical, Emphasys Medical, Evalve and The Foundry.
Related Links: www.the-foundry.com
Last Updated: Sat, Oct 25, 2008
|Video||Choosing the Right Medical Devices to Fund||Hanson Gifford · Robin Bellas||Morgenthaler||01:08||10/2004|
|Video||Morgenthaler Ventures||Hanson Gifford · Robin Bellas||Morgenthaler||01:32||10/2004|
|Video||Where Does Innovation Occur?||Hanson Gifford · Robin Bellas||Morgenthaler||01:56||10/2004|
|Video||Insight Into the Changing Valuations of Companies Since the Dot Com Era||Hanson Gifford · Robin Bellas||Morgenthaler||02:04||10/2004|
|Video||Advances in Medicine: Surgery Without Knives||Hanson Gifford · Robin Bellas||Morgenthaler||02:30||10/2004|
|Video||Examples of Groundbreaking Achievements in Medicine (Part 2)||Hanson Gifford · Robin Bellas||Morgenthaler||03:26||10/2004|
|Video||The Unique Relationship Between Morgenthaler and The Foundry||Hanson Gifford · Robin Bellas||Morgenthaler||03:35||10/2004|
|Video||The Foundry: Background||Hanson Gifford · Robin Bellas||Morgenthaler||03:50||10/2004|
|Video||Examples of Groundbreaking Achievements in Medicine (Part 1)||Hanson Gifford · Robin Bellas||Morgenthaler||05:09||10/2004|
|Video||Why Does The Foundry Work as an Incubator?||Hanson Gifford · Robin Bellas||Morgenthaler||06:45||10/2004|